Nuffield Dept of Women's & Reproductive Health, University of Oxford’s Post

A new study on chronic pelvic pain (CPP) has just been published in Science Direct. CPP is a debilitating condition, affecting millions of people worldwide (estimated prevalence of 26% worldwide) with persistent pain in the lower abdomen or pelvis that disrupts daily life. But there’s hope on the horizon! Researchers have identified a genetic marker linked to how well gabapentin works for treating CPP. This breakthrough could lead to more personalised and effective therapies, offering faster relief and improved quality of life for those who suffer from this challenging condition. https://lnkd.in/eiSRXtMv #MedicalResearch #ChronicPelvicPain #HealthBreakthrough #Endometriosis #CPP #PelvicPain #PersonalisedMedicine #WomensHealth

New Research Identifies Potential Genetic Marker for Gabapentin Efficacy in Treating Chronic Pelvic Pain

New Research Identifies Potential Genetic Marker for Gabapentin Efficacy in Treating Chronic Pelvic Pain

wrh.ox.ac.uk

To view or add a comment, sign in

Explore topics